Growth Metrics

Marimed (MRMD) Free Cash Flow (2016 - 2025)

Marimed has reported Free Cash Flow over the past 13 years, most recently at $3.4 million for Q4 2025.

  • Quarterly Free Cash Flow rose 330.86% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, up 3288.65% year-over-year, with the annual reading at $6.5 million for FY2025, 226.14% up from the prior year.
  • Free Cash Flow was $3.4 million for Q4 2025 at Marimed, up from $1.4 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $10.6 million in Q3 2021 and troughed at -$10.4 million in Q4 2022.
  • The 5-year median for Free Cash Flow is $1.7 million (2024), against an average of $1.4 million.
  • Year-over-year, Free Cash Flow soared 1788.33% in 2021 and then crashed 337.4% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at $4.4 million in 2021, then crashed by 337.4% to -$10.4 million in 2022, then skyrocketed by 173.91% to $7.7 million in 2023, then crashed by 119.13% to -$1.5 million in 2024, then skyrocketed by 330.86% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Free Cash Flow are $3.4 million (Q4 2025), $1.4 million (Q3 2025), and -$1.3 million (Q2 2025).